Citation Impact
4 from Science/Nature 73 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Oesophageal cancer
2024 Standout
Works of M.-H. Ryu being referenced
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
2020
Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
2010
Author Peers
| Author | PRM | Oncology | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| M.-H. Ryu | 358 | 292 | 195 | 26 | 568 | |
| Birgit Pils | 6 | 9 | 8 | 429 | ||
| Michael A. Scherlag | 9 | 1 | 98 | 8 | 549 | |
| Amy Prosser | 4 | 29 | 6 | 1.0k | ||
| Tsann Lin | 54 | 94 | 49 | 17 | 542 | |
| Rado Janša | 92 | 25 | 58 | 17 | 327 |
All Works
Login with ORCID to disown or claim papers
Loading papers...